Cannabis Rescheduling Review Still Ongoing

The federal government is still taking its time on the long-awaited plan to move cannabis to Schedule III. Despite President Trump previously hinting that a final call was coming "within weeks," the White House recently confirmed the review process is still just "ongoing." This delay comes even as the administration signed off on a ban for most consumable hemp products, leaving many tokers wondering if the momentum for broader reform is stalling. While Trump has shown support for medical use and better banking options for the industry, his recent comments suggest he’s still weighing the "complicated" nature of the plant.

This waiting game is a major deal for the community because rescheduling would be a massive step toward ending the outdated "Schedule I" stigma and opening doors for legitimate research and banking. For regular users, federal movement is the key to seeing better prices, more consistency, and a more stable legal market. While the political wheels turn slowly, having the conversation alive at the highest levels shows that our culture is finally getting the serious attention it deserves.